Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In the face of abrupt weight loss, one of the most common consequences is hair loss, even after bariatric surgery. Losing ...

Under medical supervision, GLP-1 agonists often lead to safe, sustainable weight loss, as noted in clinical reviews ... for a full list of side effects. Zepbound is a GLP-1 agonist containing ...

During your appointment, the healthcare professional reviews your medical history, discusses any health concerns, and assesses your weight loss goals to determine whether Zepbound suits you.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.